141 related articles for article (PubMed ID: 37808069)
21. Integrative analysis of clinical health records, imaging and pathogen genomics identifies personalized predictors of disease prognosis in tuberculosis.
Sambarey A; Smith K; Chung C; Arora HS; Yang Z; Agarwal P; Chandrasekaran S
medRxiv; 2022 Jul; ():. PubMed ID: 35898335
[TBL] [Abstract][Full Text] [Related]
22. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis.
Ralph AP; Ardian M; Wiguna A; Maguire GP; Becker NG; Drogumuller G; Wilks MJ; Waramori G; Tjitra E; Sandjaja ; Kenagalem E; Pontororing GJ; Anstey NM; Kelly PM
Thorax; 2010 Oct; 65(10):863-9. PubMed ID: 20861290
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
Bastos ML; Cosme LB; Fregona G; do Prado TN; Bertolde AI; Zandonade E; Sanchez MN; Dalcolmo MP; Kritski A; Trajman A; Maciel ELN
BMC Infect Dis; 2017 Nov; 17(1):718. PubMed ID: 29137626
[TBL] [Abstract][Full Text] [Related]
24. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
[TBL] [Abstract][Full Text] [Related]
25. Differences in pulmonary nodular consolidation and pulmonary cavity among drug-sensitive, rifampicin-resistant and multi-drug resistant tuberculosis patients: a computerized tomography study with history length matched cases.
Song QS; Zheng CJ; Wang KP; Huang XL; Tartakovsky M; Wáng YXJ
J Thorac Dis; 2022 Jul; 14(7):2522-2531. PubMed ID: 35928612
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis Chest X-Ray Image Retrieval System Using Deep Learning Based Biomarker Predictions.
Lowekamp BC; Gabrielian A; Hurt DE; Rosenthal A; Yaniv Z
Proc SPIE Int Soc Opt Eng; 2024 Feb; 12931():. PubMed ID: 38616847
[TBL] [Abstract][Full Text] [Related]
27. The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya.
van Cleeff MR; Kivihya-Ndugga LE; Meme H; Odhiambo JA; Klatser PR
BMC Infect Dis; 2005 Dec; 5():111. PubMed ID: 16343340
[TBL] [Abstract][Full Text] [Related]
28. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
29. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
[TBL] [Abstract][Full Text] [Related]
30. Outcome of multi-drug resistant tuberculosis cases treated by individualized regimens at a tertiary level clinic.
Dhingra VK; Rajpal S; Mittal A; Hanif M
Indian J Tuberc; 2008 Jan; 55(1):15-21. PubMed ID: 18361306
[TBL] [Abstract][Full Text] [Related]
31. Sputum smear conversion and treatment outcomes among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia: A 9-years data analysis.
Gamachu M; Deressa A; Birhanu A; Ayana GM; Raru TB; Negash B; Merga BT; Alemu A; Ahmed F; Mohammed A; Abdulahi IM; Regassa LD
Front Med (Lausanne); 2022; 9():1007757. PubMed ID: 36530886
[TBL] [Abstract][Full Text] [Related]
32. Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital.
Ncha R; Variava E; Otwombe K; Kawonga M; Martinson NA
S Afr J Infect Dis; 2019; 34(1):111. PubMed ID: 34485452
[TBL] [Abstract][Full Text] [Related]
33. Different profiles of body mass index variation among patients with multidrug-resistant tuberculosis: a retrospective cohort study.
Diallo A; Diallo BD; Camara LM; Kounoudji LAN; Bah B; N'Zabintawali F; Carlos-Bolumbu M; Diallo MH; Sow OY
BMC Infect Dis; 2020 Apr; 20(1):315. PubMed ID: 32345228
[TBL] [Abstract][Full Text] [Related]
34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
35. Treatment of multidrug-resistant tuberculosis in Thailand.
Maranetra KN
Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
[TBL] [Abstract][Full Text] [Related]
36. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
37. Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study - Not all rifampicin resistance is multi-drug resistant.
Kenaope L; Ferreira H; Seedat F; Otwombe K; Martinson NA; Variava E
J Glob Antimicrob Resist; 2020 Jun; 21():434-438. PubMed ID: 31733411
[TBL] [Abstract][Full Text] [Related]
38. Low pectoralis muscle index, cavitary nodule or mass and segmental to lobar consolidation as predictors of primary multidrug-resistant tuberculosis: A comparison with primary drug sensitive tuberculosis.
Shin HS; Choi DS; Na JB; Choi HY; Kim JE; Choi HC; Won JH; Lee SJ; Park MJ
PLoS One; 2020; 15(10):e0239431. PubMed ID: 33017424
[TBL] [Abstract][Full Text] [Related]
39. Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study.
Molie T; Teklemariam Z; Klinkenberg E; Dessie Y; Kumsa A; Mohammed H; Debebe A; Assefa D; Habte A; Bedru A; Fiseha D; Seyoum B
BMC Infect Dis; 2019 Sep; 19(1):818. PubMed ID: 31533644
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
